קם-רהו די I.M

Krajina: Izrael

Jazyk: hebrejčina

Zdroj: Ministry of Health

Aktívna zložka:

ANTI-D IMMUNOGLOBULINS

Dostupné z:

KAMADA LTD, ISRAEL

ATC kód:

J06BB01

Forma lieku:

תמיסה להזרקה

Zloženie:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Spôsob podávania:

תוך-שרירי

Typ predpisu:

מרשם נדרש

Výrobca:

KAMADA LTD, ISRAEL

Terapeutické skupiny:

ANTI-D (RH) IMMUNOGLOBULIN

Terapeutické oblasti:

ANTI-D (RH) IMMUNOGLOBULIN

Terapeutické indikácie:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

Dátum Autorizácia:

2022-01-31